Cargando…
TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies
Microglial cells in the central nervous system (CNS) are crucial in maintaining a healthy environment for neurons to function properly. However, aberrant microglial cell activation can lead to excessive generation of neurotoxic proinflammatory mediators and neuroinflammation, which represents a cont...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423084/ https://www.ncbi.nlm.nih.gov/pubmed/30914955 http://dx.doi.org/10.3389/fphar.2019.00239 |
_version_ | 1783404478348656640 |
---|---|
author | Malko, Philippa Syed Mortadza, Sharifah A. McWilliam, Joseph Jiang, Lin-Hua |
author_facet | Malko, Philippa Syed Mortadza, Sharifah A. McWilliam, Joseph Jiang, Lin-Hua |
author_sort | Malko, Philippa |
collection | PubMed |
description | Microglial cells in the central nervous system (CNS) are crucial in maintaining a healthy environment for neurons to function properly. However, aberrant microglial cell activation can lead to excessive generation of neurotoxic proinflammatory mediators and neuroinflammation, which represents a contributing factor in a wide spectrum of CNS pathologies, including ischemic stroke, traumatic brain damage, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, psychiatric disorders, autism spectrum disorders, and chronic neuropathic pain. Oxidative stress is a salient and common feature of these conditions and has been strongly implicated in microglial cell activation and neuroinflammation. The transient receptor potential melastatin-related 2 (TRPM2) channel, an oxidative stress-sensitive calcium-permeable cationic channel, is highly expressed in microglial cells. In this review, we examine the recent studies that provide evidence to support an important role for the TRPM2 channel, particularly TRPM2-mediated Ca(2+) signaling, in mediating microglial cell activation, generation of proinflammatory mediators and neuroinflammation, which are of relevance to CNS pathologies. These findings lead to a growing interest in the TRPM2 channel, a new player in neuroinflammation, as a novel therapeutic target for CNS diseases. |
format | Online Article Text |
id | pubmed-6423084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64230842019-03-26 TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies Malko, Philippa Syed Mortadza, Sharifah A. McWilliam, Joseph Jiang, Lin-Hua Front Pharmacol Pharmacology Microglial cells in the central nervous system (CNS) are crucial in maintaining a healthy environment for neurons to function properly. However, aberrant microglial cell activation can lead to excessive generation of neurotoxic proinflammatory mediators and neuroinflammation, which represents a contributing factor in a wide spectrum of CNS pathologies, including ischemic stroke, traumatic brain damage, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, psychiatric disorders, autism spectrum disorders, and chronic neuropathic pain. Oxidative stress is a salient and common feature of these conditions and has been strongly implicated in microglial cell activation and neuroinflammation. The transient receptor potential melastatin-related 2 (TRPM2) channel, an oxidative stress-sensitive calcium-permeable cationic channel, is highly expressed in microglial cells. In this review, we examine the recent studies that provide evidence to support an important role for the TRPM2 channel, particularly TRPM2-mediated Ca(2+) signaling, in mediating microglial cell activation, generation of proinflammatory mediators and neuroinflammation, which are of relevance to CNS pathologies. These findings lead to a growing interest in the TRPM2 channel, a new player in neuroinflammation, as a novel therapeutic target for CNS diseases. Frontiers Media S.A. 2019-03-12 /pmc/articles/PMC6423084/ /pubmed/30914955 http://dx.doi.org/10.3389/fphar.2019.00239 Text en Copyright © 2019 Malko, Syed Mortadza, McWilliam and Jiang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Malko, Philippa Syed Mortadza, Sharifah A. McWilliam, Joseph Jiang, Lin-Hua TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies |
title | TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies |
title_full | TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies |
title_fullStr | TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies |
title_full_unstemmed | TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies |
title_short | TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies |
title_sort | trpm2 channel in microglia as a new player in neuroinflammation associated with a spectrum of central nervous system pathologies |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423084/ https://www.ncbi.nlm.nih.gov/pubmed/30914955 http://dx.doi.org/10.3389/fphar.2019.00239 |
work_keys_str_mv | AT malkophilippa trpm2channelinmicrogliaasanewplayerinneuroinflammationassociatedwithaspectrumofcentralnervoussystempathologies AT syedmortadzasharifaha trpm2channelinmicrogliaasanewplayerinneuroinflammationassociatedwithaspectrumofcentralnervoussystempathologies AT mcwilliamjoseph trpm2channelinmicrogliaasanewplayerinneuroinflammationassociatedwithaspectrumofcentralnervoussystempathologies AT jianglinhua trpm2channelinmicrogliaasanewplayerinneuroinflammationassociatedwithaspectrumofcentralnervoussystempathologies |